logo
Iron and pregnancy—a delicate balance
Body iron and individual iron prophylaxis in pregnancy—should the iron dose be adjusted according to serum ferritin?
Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas
Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A)
Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy
Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma
Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis
Constitutional pericentric inversion of chromosome 9 and hematopoietic recovery after allogeneic stem cell transplantation
Severe diarrhoea during Campath-1H treatment for refractory cutaneous T-cell lymphoma
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder
Rituximab as first line treatment for MALT lymphoma of extraocular muscles
Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma
Disseminated herpes virus (HSV-2) infection with rhabdomyolysis and hemophagocytic lymphohistiocytosis in a patient with bone marrow failure syndrome
Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab
Acute splenic sequestration crisis in an adult with sickle β-thalassemia
The hematopathological basis for studying effects of the demethylating agent 5-aza-2′-deoxycytidine (decitabine) in myelodysplasia
Management of sepsis in neutropenia
7th International Lübeck Conference on the Pathophysiology and Pharmacology of Erythropoietin and other Hemopoietic Growth Factors